Table 1.
Cardio-pulmonary bypass and pulmonary resection
| Studies | Number | Primary tumor | Lung resection | Structure involved | Morbidity | Mortality (%) | Survival |
|---|---|---|---|---|---|---|---|
| Vaporciyan. 2002 [22] | 19 | Sarcoma (n = 9) Epithelial (n = 7) Others (n = 1) |
PN (n = 5) Lobectomy (n = 3) |
Great vessels (5 PA, 1 Ao, 5 IVC, 1 SVC) Heart (5 LA, 6 RA) |
Overall 58 %: Pneumonia (37 %) Bleeding (21 %) Tracheotomy (16 %) |
11 | Curative intent (median): 64 months Palliative: 11 months |
| Park. 2004 [28] | 10 | Sarcoma (n = 7) Others (n = 3) |
PN (n = 2) Lobectomy (n = 3) |
Great vessels (5 SVC, 1 PA, 1 Aorta) Heart (4 LA, 2 RA) |
Overall 50 % Re-operation 50 % | 0 | Complete resection (median: 33.3 months) |
| De Perrot. 2005 [23] | 7 | NSCLC (n = 7) | PN (n = 4) Lobectomy (n = 2) Carina (n = 1) |
Great Vessels (2 SA, 1 Ao, 2 PA) Heart (2 LA) Carina 2 |
Overall (58 %) ARDS (1) | 0 | 6/7 alive |
| Wiebe. 2006 [24] | 13 | Sarcoma (n = 8) NSCLC (n = 3) Others (n = 2) |
PN (n = 9) Lobectomy (n = 4) |
Great Vessels (PA 6, PV 3, Ao 1, SVC 1) Heart (LA 9, RA 3) |
ALI (n = 4) Right heart failure (n = 1) MOF (n = 1) |
15 | Sarcoma 62 % at 5-year NSCLC 33 % at 5-year |
| Byrne. 2004 [25] | 14 | NSCLC (n = 7) Sarcoma (n = 5) Mesothelioma (n = 1) Thymic carcinoma (n = 1) |
PN (n = 10) Lobectomy (n = 3) Wedge (n = 1) |
Great vessels (PA 4, SVC 3, IVC 2 Heart (LA 3) |
Low cardiac output syndrom (5/14) Re-operation for bleeding (3/14) Stroke (n = 1) Pulmonary edema (n = 1) |
0 | 21 % at 5-year |
NSCLC non-small cell lung cancer, LA left atrium, RA right atrium, SVC superior vena cava, IVC inferior vena cava, Ao aorta, PA main pulmonary artery or pulmonary trunk, PN pneumonectomy, ALI acute lung injury